Results 231 to 240 of about 8,292 (268)
CDR clipping-induced heterodimerization: identification of a novel dimerization mechanism in a co-formulated antibody cocktail via a multifaceted mass spectrometry approach. [PDF]
Heindel AJ +5 more
europepmc +1 more source
A one‐step gas‐phase synthesis directly assembles amorphous Si nanoparticles with few‐layer graphene heterostructures via in‐flight mixing. Compositions with only 15 wt.% FLG deliver ~2800 mAh g−1 (Si + FLG) at 0.05 C and retain ~1400 mAh g−1 after 100 cycles at a high cycling rate of 1 C, enabled by a percolated, strain‐buffering graphene network that
Muhammad Ali +5 more
wiley +1 more source
An integrated cell and medium engineering approach for production of a nanobody fusion in Saccharomyces cerevisiae. [PDF]
Niemelä LRK +4 more
europepmc +1 more source
ABSTRACT As global climate ambitions intensify, the key challenge lies not in setting renewable energy targets but in designing governance systems that can translate them into lasting transformation. The transition management literature has advanced a valuable research agenda for initiating change through niche innovations and participatory arenas in ...
Alexander L. Q. Chen‐Florea +2 more
wiley +1 more source
Structural basis of nectin-4 recognition by the antibody-drug conjugate 9MW2821. [PDF]
Fang P +12 more
europepmc +1 more source
A new family of phosphorescent Pt(II) complexes with pyrimidinedipyrrolide ligands, including a pyrazine analog, was designed and synthesized. Their emission properties can be finely tuned via ligand modification, revealing strong phosphorescence originating from intraligand charge transfer transitions.
Marcela Horáková +7 more
wiley +1 more source
Pharmacological considerations for next-generation protein therapeutics in cardiovascular disease. [PDF]
Lin E, Momin N.
europepmc +1 more source
Longitudinal changes in the abundance of IgA1 O- and N-glycoforms in IgA nephropathy. [PDF]
Hirayama M +7 more
europepmc +1 more source
Successful treatment of lung squamous cell carcinoma with envafolimab, a PD-L1 inhibitor combined with chemotherapy: a case report. [PDF]
Sun X +8 more
europepmc +1 more source

